[Pharmacological properties of chitosan-coated dialdehyde cellulose (chitosan DAC), a newly developed oral adsorbent (I). Effect of chitosan DAC in normal rats].
The effects of chitosan-coated dialdehyde cellulose (chitosan DAC), a newly developed oral adsorbent of urea and ammonia, were examined in an in vitro adsorption study and in normal rats. Chitosan DAC showed high adsorption capacity for urea and ammonia in an in vitro study using the diluted supernatant of rat gastrointestinal fluid. In contrast, Kremezin, an oral charcoal adsorbent (AST-120), had little influence on these substances. In normal rats fed diets containing chitosan DAC (1, 2, 3, 4, 5, 7, and 10% content) for three weeks, increases in fecal wet weight, fecal dry weight and fecal water content were observed in a dose-dependent manner. In addition, chitosan DAC feeding increased fecal excretion of nitrogen and electrolytes (sodium, potassium and chloride ions) and decreased the apparent protein ratio in a dose-dependent manner. There were no obvious effects in serum parameters except that increased levels of protein and albumin and decreased levels of blood urea nitrogen, cholesterol and glucose were observed in rats fed a high concentration of chitosan DAC. In conclusion, these findings suggest the possibility that chitosan DAC treatment might be effective for improving chronic renal failure.